Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverse effects registry considered a high priority by OAM advisory council.

This article was originally published in The Tan Sheet

Executive Summary

ALTERNATIVE MEDICINE ADVERSE EFFECTS REGISTRY IS HIGH PRIORITY FOR OAM, members of the Office of Alternative Medicine's program advisory council agreed at a Feb. 27 meeting in Bethesda, Md. OAM Director Wayne Jonas, MD, posited the registry as one of several potential priorities for the office, asking for the council's recommendations. "I think the adverse effects registry is something that is going to be very important" in order to make decisions about "benefit-to-risk ratios" of disease treatments, he commented.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084830

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel